The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

A second chikungunya vaccine may soon be available for travelers, officials say TUESDAY, May 13, 2025 (HealthDay News) — U.S.

From the anti-vaccine movement and COVID denialism to the promotion of raw pet food, the wellness-industrial complex has ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.